These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 792579)

  • 61. Renal allograft immunosuppression. II. A randomized trial of withdrawal of one drug in triple drug immunosuppression.
    Isoniemi H; Ahonen J; Eklund B; Höckerstedt K; Salmela K; von Willebrand E; Häyry P
    Transpl Int; 1990 Oct; 3(3):121-7. PubMed ID: 2271083
    [TBL] [Abstract][Full Text] [Related]  

  • 62. High intravenous doses of methylprednisolone for acute cadaveric renal allograft rejection.
    Mussche MM; Ringoir SM; Lameire NN
    Nephron; 1976; 16(4):287-91. PubMed ID: 765873
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Combination drug treatment in immunosuppression. Effect of azathioprine, cyclophosphamide, and methylprednisolone on rabbit renal allografts.
    Friedman EA; Ueno A; Beyr MM; Nicastri AD
    Transplantation; 1973 Jun; 15(6):619-23. PubMed ID: 4577157
    [No Abstract]   [Full Text] [Related]  

  • 64. Failure of blood transfusions to improve cadaveric renal allograft survival.
    Jeffery JR; Downs A; Grahame JW; Lye C; Ramsey E; Thomson AE
    Transplantation; 1978 Jun; 25(6):344-5. PubMed ID: 351896
    [No Abstract]   [Full Text] [Related]  

  • 65. High- versus low-dose methylprednisolone for acute rejection episodes in renal transplantation.
    Park GD; Bartucci M; Smith MC
    Nephron; 1984; 36(2):80-3. PubMed ID: 6363949
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Improved survival after donor pretreatment with anti-lymphoblast globulin (ALG) in perfused kidneys: experimental findings.
    Toledo-Pereyra LH; Taiyebb S; McKenzie GH; Gordon DA; Sy GS
    J Surg Res; 1981 Aug; 31(2):172-7. PubMed ID: 7022024
    [No Abstract]   [Full Text] [Related]  

  • 67. Donor pretreatment with cyclophosphamide and methylprednisolone.
    Brom HL; van Breda Vriesman PJ
    Transplantation; 1983 Jul; 36(1):106-7. PubMed ID: 6408773
    [No Abstract]   [Full Text] [Related]  

  • 68. [Immunosuppressive therapy following penetrating keratoplasty (author's transl)].
    Gnad HD
    Ophthalmologica; 1980; 180(1):9-14. PubMed ID: 7003468
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of cyclophosphamide and methylprednisolone on in vitro cellular immune response to allogeneic tumor cells. Correlation with in vivo rejection.
    Gerber M; Andress D; Pioch Y; Radal M; Serrou B
    Transplantation; 1978 Sep; 26(3):142-9. PubMed ID: 309196
    [No Abstract]   [Full Text] [Related]  

  • 70. Use of cyclophosphamide and enhancing serum to suppress renal allograft rejection in the rat.
    Winearls CG; Fabre JW; Millard PR; Morris PJ
    Transplantation; 1979 Oct; 28(4):271-4. PubMed ID: 388758
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Letter: Steroids and cyclophosphamide dosage in renal allograft perfusion.
    Woods JE; Zincke H
    Transplantation; 1976 Mar; 21(3):260. PubMed ID: 781925
    [No Abstract]   [Full Text] [Related]  

  • 72. The influence of pretransplant and posttransplant immunosuppression on cardiac graft survival in the donor-specific transfusion model in mice. Comparison of the effects of cyclophosphamide, procarbazine, cyclosporine, and cortisone.
    Lasek W; Jakóbisiak M; Grochowska M; Górecki D; Gniadecki R; Kaliński P
    Transplantation; 1989 May; 47(5):913-5. PubMed ID: 2655232
    [No Abstract]   [Full Text] [Related]  

  • 73. The effect of high dose steroid and cyclophosphamide on perfused canine renal homografts.
    Tremann JA; Haines JG; Bleifuss JH; Agodoa LC; Marchioro TL
    Transplantation; 1975 Jun; 19(6):520-2. PubMed ID: 1094642
    [No Abstract]   [Full Text] [Related]  

  • 74. Rat heart allograft survival with donor pretreatment.
    Freeman JS; Chamberlain E; Reemtsma K; Steinmuller D
    Circulation; 1971 May; 43(5 Suppl):I120-3. PubMed ID: 4931286
    [No Abstract]   [Full Text] [Related]  

  • 75. Prolongation of rat cardiac allograft survival by donor pretreatment. Impact of dose and timing of drug administration.
    Soots A; Häyry P
    Scand J Thorac Cardiovasc Surg; 1979; 13(1):83-6. PubMed ID: 373096
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Controlled trial of two different methylprednisolone doses in cadaveric renal transplantation.
    De Vecchi A; Rivolta E; Tarantino A; Egidi F; Berardinelli L; Vegeto A; Ponticelli C
    Nephron; 1985; 41(3):262-6. PubMed ID: 3903528
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Photochemical donor pretreatment in clinical kidney transplantation--preliminary report.
    Oesterwitz H; Scholz D; Kaden J; May G; Mebel M; Schirrow R; Blank W
    Urol Res; 1987; 15(4):211-3. PubMed ID: 3314074
    [TBL] [Abstract][Full Text] [Related]  

  • 78. High dose (bolus) intravenous methylprednisolone at the time of kidney homotransplantation.
    Kauffman HM; Sampson D; Fox PS; Stawicki AT
    Ann Surg; 1977 Nov; 186(5):631-4. PubMed ID: 335989
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Transmission of toxoplasmosis by renal transplant.
    Mejia G; Leiderman E; Builes M; Henao J; Arbelaez M; Arango JL; Borrero J
    Am J Kidney Dis; 1983 May; 2(6):615-7. PubMed ID: 6342373
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Lymphocyte sensitivity to glucocorticoids before and after cadaver kidney transplantation.
    Langhoff E; Ladefoged J
    Transplantation; 1985 Mar; 39(3):318-20. PubMed ID: 3883598
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.